MMWR Morb Mortal Wkly Rep. 1992 Oct 9;41(40):739-43.
Breast cancer is the most commonly diagnosed cancer and the second leading cause of cancer deaths among women in the United States. During 1992, breast cancer will be diagnosed in 180,000 women, and an estimated 46,000 women will die from the disease (1). In addition, invasive cervical cancer will be diagnosed in an estimated 13,500 women and will cause approximately 4400 deaths (1). Many of these deaths could be prevented through routine, high-quality mammography screening and use of the Papanicolaou (Pap) test (2,3). This report describes cancer screening in three women who received these services through CDC's National Breast and Cervical Cancer Early Detection Program and the implementation of this comprehensive screening program for low-income women through cooperative agreements with state health agencies during July 1991-July 1992.
乳腺癌是美国女性中最常被诊断出的癌症，也是癌症死亡的第二大主要原因。1992年期间，将有18万名女性被诊断出患有乳腺癌，估计有4.6万名女性将死于该疾病（1）。此外，估计将有1.35万名女性被诊断出患有浸润性宫颈癌，并将导致约4400人死亡（1）。通过常规的高质量乳房X光筛查和巴氏试验，许多此类死亡是可以预防的（2,3）。本报告描述了三名通过疾病控制与预防中心的国家乳腺癌和宫颈癌早期检测项目接受这些服务的女性的癌症筛查情况，以及在1991年7月至1992年7月期间通过与州卫生机构签订合作协议为低收入女性实施这一综合筛查项目的情况。
